In conclusion, many tumors such as mesothelioma and ovarian serous carcinoma showed equal immunoreactivity with both 5B2 and MN-1 antibodies, however, differences in mesothelin expression were seen in other tumor types using 5B2 or MN-1 antibodies. The gene discussed is MSLN; the disease is mesothelioma.